Los Angeles, CA - CBio was picked as one of the most innovative companies in Southern California, and its CEO, David Charlot, was an invited speaker for the Life Sciences panel. The event, hosted by Alliance for SoCal Innovation and Los Angeles Venture Association, was held last June 20 at the Luskin Conference Center at the University of California in Los Angeles.
SoCal Innovation Showcase featured a blend of world-class keynote speakers, startup success stories, early-stage research teams, and moderated panel discussions that showcased the amazing breadth and depth of SoCal’s vibrant innovation sectors.
David and other experts discussed opportunities and next generation technologies in Life Sciences, as well as how SoCal’s innovation ecosystem thrives on a robust, diverse culture.
About Dr. Charlot
David is an experienced inventor, entrepreneur, and manager with 15 years experience building tools to solve challenges in human health. He is a knowledgeable bioengineer with specialization in automation and systems integration for live cell analysis. He received his PhD in bioengineering from University of California, San Diego and BSc in physics from Delaware State University. David has 18 device patents for DNA and Cell Analysis issued in the US.
As CEO of CBio, David leads a multidisciplinary team to implement his vision to provide access to novel tools clinicians and researchers need to detect treatable disease early. His core passions are providing access to advanced live cell analysis tools and expanding opportunities in STEM education. He believes empowering the next generation of researchers with disruptive technology will spark their creativity and reshape the future of clinical diagnostics.
CBio is a life science tools company equipping researchers and clinicians with tools to help them identify predictive signatures of disease. Our proprietary cellPhoresis™ platform enables the study of living cells. Our technology identifies subtle differences between Normal and Abnormal living cells, preserves function, and retains usability for further study.